Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Targeted oncology
- Publicado em
- 29 jun 2022
- Citações
- 32
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer
Elaine S Tan, Wenyi Fan, Todd C Knepper, Michael J Schell, Ibrahim H Sahin, Jason B Fleming, Hao Xie
Descritores MeSH
- Colorectal Neoplasms
- Colonic Neoplasms
- Mutation
- Prognosis
- Retrospective Studies
- Biomarkers, Tumor
- Proto-Oncogene Proteins p21(ras)
- Phosphatidylinositol 3-Kinases
- Proto-Oncogene Proteins B-raf
- Class I Phosphatidylinositol 3-Kinases
Veja também
Estudos relacionados
- Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
- Prognostic significance of KRAS, NRAS, BRAF, and PIK3CA mutations in stage II/III colorectal cancer: A retrospective study and meta-analysis
- Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database
- The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches